Skip to main content
GileadTech adoption

AUTM on the Air discusses Gilead: tech adoption

Source

Quotes from the episode

  • “In the case of Gilead, actually Remdesivir, or the treatment of COVID-19, is one of the medications that use the Captisol technology.”

    Ruben Flores-SaaibAUTM on the AirView

Extracted by Autobound

From the Signal API record
Signal
Tech adoption

What this signalsWhat leaders say on podcasts often shows their current priorities.

Podcast
AUTM on the Air
Speaker
Ruben Flores-Saaib
Speaker role
Counterparty
Event date
Feb 2024

Latest signals at other companies

The full record

From the Signal API record

People

  • Ruben Flores-SaaibSpeaker (counterparty)

Details

Timing
Ongoing state
Recorded at estimate
2024-02

Extraction

Detected
Aug 24, 2026
signal_type
podcast-company
signal_subtype
techAdoption

Use this data

Get every podcast signal for Gilead and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Gilead this week?”

  2. Send it to your own tools

    The Signal API returns podcast signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full podcast-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/cfc3dfad-2f0d-568d-bee6-20d8e26d989d returns this record as JSON. POST /v1/companies/enrich returns every signal for gilead.com.

{
  "signal_id": "cfc3dfad-2f0d-568d-bee6-20d8e26d989d",
  "signal_type": "podcast-company",
  "signal_subtype": "techAdoption",
  "detected_at": "2026-08-24T10:25:12+00:00",
  "company": {
    "name": "Gilead",
    "domain": "gilead.com"
  },
  "data": {
    "is_ad": false,
    "quotes": [
      "In the case of Gilead, actually Remdesivir, or the treatment of COVID-19, is one of the medications that use the Captisol technology."
    ],
    "timing": "ongoing_state",
    "speaker": "Ruben Flores-Saaib",
    "evidence": "In the case of Gilead, actually Remdesivir, or the treatment of COVID-19, is one of the medications that use the Captisol technology.",
    "headline": "Gilead Sciences · techAdoption · ongoing_state (2024-02)",
    "episode_id": "57938098357",
    "event_date": "2024-02",
    "episode_url": "https://autm.net",
    "podcast_name": "AUTM on the Air",
    "published_at": "2026-07-22",
    "episode_title": "Advancing Biopharma Innovation with Ruben Flores-Saaib",
    "date_confidence": "inferred",
    "speaker_relation": "counterparty",
    "transcript_source": "transcript",
    "recorded_at_estimate": "2024-02"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.